Skip to content

Randomized Trial of Vitamin B12 in Pregnant Indian Women

Randomized Trial of Vitamin B12 in Pregnant Indian Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00641862
Acronym
B12
Enrollment
366
Registered
2008-03-24
Start date
2008-12-31
Completion date
2011-01-31
Last updated
2020-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Keywords

Pregnancy, Maternal Nutritional Status, Vitamin B12

Brief summary

This study is a randomized, double-blind trial among 300 pregnant Indian women in order to determine the effectiveness of vitamin B12 supplementation in improving maternal B12 status. Secondary aims for this trial include maternal hemoglobin, maternal weight gain during pregnancy and infant birthweight. All women will receive standard of prenatal obstetric care, including routine supplementation with iron and folate.

Detailed description

The incidence of poor fetal growth and adverse maternal and infant birth outcomes is quite high in India, and several lines of evidence suggest that maternal nutritional status may be an important factor. We have previously performed extensive evaluations of poor fetal and infant outcomes in other settings, and found that maternal micronutrient supplementation (B vitamins including vitamin B12, plus vitamins C and E) in HIV positive Tanzanian mothers decreased the risk of low birthweight (\<2500 g) by 44% (RR (95% CI) 0.56 (0.38-0.82)), severe preterm birth (\<34 weeks of gestation) by 39% (RR 0.61 (0.38-0.96)), and small size for gestational age at birth by 43% (RR 0.57 (0.39-0.82)). In a prospective cohort study of 410 pregnant Indian women, we recently found a strong relationship between maternal serum vitamin B12 concentration and risk of infant intrauterine growth retardation (IUGR). Compared to women in the highest tertile of serum B12 concentration, women in the lowest tertile were significantly more likely to have IUGR infants, after controlling for maternal age, weight, education, and parity (OR (95% CI) 5.98 (1.72-20.74)). We now propose a randomized, double-blind trial among 300 pregnant Indian women in order to determine the effectiveness of vitamin B12 supplementation (50 µg daily) in improving maternal B12 status. Secondary aims for this exploratory trial include maternal hemoglobin, maternal weight gain during pregnancy and infant birthweight. All women will receive standard of prenatal obstetric care, including routine supplementation with iron and folate. The study will be a collaborative effort between the Division of Nutrition, St John's Research Institute, Bangalore, India, and the Department of Nutrition, Harvard School of Public Health, Boston, US.

Interventions

DIETARY_SUPPLEMENTVitamin B12

Daily oral administration of 50 µg of Vitamin B12 taken from enrollment (at or before 14 weeks gestational age) until delivery

OTHERPlacebo

Placebo taken daily from enrollment (at or before 14 weeks gestational age) until delivery

Sponsors

St. John's Research Institute
CollaboratorOTHER
Harvard School of Public Health (HSPH)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Pregnant women at or before 14 weeks gestational age.

Exclusion criteria

* Women who anticipate moving outside of the study area before study completion * Those with twin or multiple pregnancies * Those who test positive for hepatitis B (HepBSAg), HIV or Syphilis (VDRL) * Those taking vitamin supplements in addition to folate and iron * Those with a serious pre-existing medical condition, defined as conditions that require chronic or daily medical therapy such as connective tissue diseases, hypertension not related to pregnancy, inflammatory bowel disease, active tuberculosis, symptomatic heart disease, and insulin dependent diabetes.

Design outcomes

Primary

MeasureTime frame
Changes in Maternal Serum B12 Concentration From 1st to 3rd Trimesterfrom 1st to 3rd trimester

Secondary

MeasureTime frameDescription
Receptive Language Scale, Bayley Scales of Infant Development, 3rd Edition9 monthsThe Receptive Language Scale is a single scale that measures the ability of the child to recognize sounds and understand spoken words and directions. Higher values represent better performance. The interquartile range provides adequate assessment of the variability of the data. The minimum possible score is 0 and the maximum possible score is 49.
Expressive Language Scale, Bayley Scales of Infant Development, 3rd Edition9 monthsThe Expressive Language Scale is a single scale that measures the ability of the child to communicate using sounds, gestures, or words. Higher scores represent better performance. The interquartile range provides adequate assessment of the variability of the data. The minimum possible value is 0 and the maximum possible value is 48.
Fine Motor Scale, Bayley Scales of Infant Development, 3rd Edition9 monthsThe Fine Motor Scale is a single scale that measures prehension, perceptual-motor integration, motor planning and speed, visual tracking, reaching, object grasping, object manipulation, functional hand skills, and responses to tactile information. Higher values represent better performance. The interquartile range provides adequate assessment of the variability of the data. The minimum possible value is 0 and the maximum possible value is 66.
Gross Motor Scale, Bayley Scales of Infant Development, 3rd Edition9 monthsThe Gross Motor Scale is a single scale that measures movement of the limbs and torso, static positioning (e.g., sitting, standing), dynamic movement including locomotion and coordination, balance, and motor planning. Higher values represent better performance. The interquartile range provides adequate assessment of the variability of the data. The minimum possible value is 0 and the maxiumum possible value is 72.
Kaufman's Assessment Battery for Children (KABC)60-72 monthsThis test is used for assessing child intelligence
Cognitive Scale, Bayley Scales of Infant Development, 3rd Edition9 monthsThe cognitive scale is a single scale that measures sensorimotor integration, concept formation, attention, habituation, and memory. Higher values represent better performance. The interquartile range provides an adequate assessment of the variability of the data. The minimum possible score of the cognitive scale is 0 and the maximum possible score is 91.
Vineland Social Maturity Scale (VSMS)60-72 monthsThis scale has 8 main domains which include, Self Help General, Self Help Dressing, Self Direction, Occupation, Communication, Locomotion and Socialization. It is possible to calculate Social age and Social quotient from VSMS which will provide a good idea about the social maturity of the infant. VSMS will be used in conjunction with KABC at age 60-72 months of age.
The Brief P Test66 months postpartumThe Brief P test is a measure of infant executive function based on parental rating. It will be administered at 66 months postpartum.
Parental Version of Strengths and Difficulties Questionnaire (SDQ)78 monthsAdministered at 78 months to assess childhood behavioral problems. The SDQ has 25 items and generates 5 scales: emotional problem, conduct problem, hyperactivity/inattention, peer relationship problems and pro-social behavior.
Bradley Infant-Toddler Home Tools60 monthsHome tools used to analyze aspects of home environment. This scale captures information on parenting behavior under 6 domains: responsivity, acceptance, organization, learning materials, parental involvement, and variety of stimulation at home). Trained study personnel will administer this questionnaire to participating families at 60 months.
The Wechsler Preschool and Primary Scale of Intelligence (WPPSI)78 monthsWPPSI is an intelligence test designed for children ages 2 years 6 months to 7 years 7 months. It is a paper-pencil test that will be administered during the 78 month follow up to assess child's intellectual functioning.

Countries

India

Participant flow

Participants by arm

ArmCount
Vitamin B12
Vitamin B12 Vitamin B12: Daily oral administration of 50 µg of Vitamin B12 taken from enrollment (at or before 14 weeks gestational age) until delivery
183
Placebo
Placebo Placebo: Placebo taken daily from enrollment (at or before 14 weeks gestational age) until delivery
183
Total366

Baseline characteristics

CharacteristicVitamin B12PlaceboTotal
Age, Continuous22 years22 years22 years
Sex: Female, Male
Female
183 Participants183 Participants366 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1830 / 183
serious
Total, serious adverse events
0 / 1830 / 183

Outcome results

Primary

Changes in Maternal Serum B12 Concentration From 1st to 3rd Trimester

Time frame: from 1st to 3rd trimester

Population: Serum samples were available for analysis among 102 of the original 183 participants in each arm.

ArmMeasureValue (MEDIAN)
Vitamin B12Changes in Maternal Serum B12 Concentration From 1st to 3rd Trimester3.0 pmol/L
PlaceboChanges in Maternal Serum B12 Concentration From 1st to 3rd Trimester-37.6 pmol/L
Secondary

Bradley Infant-Toddler Home Tools

Home tools used to analyze aspects of home environment. This scale captures information on parenting behavior under 6 domains: responsivity, acceptance, organization, learning materials, parental involvement, and variety of stimulation at home). Trained study personnel will administer this questionnaire to participating families at 60 months.

Time frame: 60 months

Secondary

Cognitive Scale, Bayley Scales of Infant Development, 3rd Edition

The cognitive scale is a single scale that measures sensorimotor integration, concept formation, attention, habituation, and memory. Higher values represent better performance. The interquartile range provides an adequate assessment of the variability of the data. The minimum possible score of the cognitive scale is 0 and the maximum possible score is 91.

Time frame: 9 months

Population: Outcome was measured among 178 of the 366 enrolled participants.

ArmMeasureValue (MEDIAN)
Vitamin B12Cognitive Scale, Bayley Scales of Infant Development, 3rd Edition39 units on a scale
PlaceboCognitive Scale, Bayley Scales of Infant Development, 3rd Edition39.5 units on a scale
Secondary

Expressive Language Scale, Bayley Scales of Infant Development, 3rd Edition

The Expressive Language Scale is a single scale that measures the ability of the child to communicate using sounds, gestures, or words. Higher scores represent better performance. The interquartile range provides adequate assessment of the variability of the data. The minimum possible value is 0 and the maximum possible value is 48.

Time frame: 9 months

Population: This outcome was measured in 178 of the 366 enrolled participants

ArmMeasureValue (MEDIAN)
Vitamin B12Expressive Language Scale, Bayley Scales of Infant Development, 3rd Edition10 units on a scale
PlaceboExpressive Language Scale, Bayley Scales of Infant Development, 3rd Edition11 units on a scale
Secondary

Fine Motor Scale, Bayley Scales of Infant Development, 3rd Edition

The Fine Motor Scale is a single scale that measures prehension, perceptual-motor integration, motor planning and speed, visual tracking, reaching, object grasping, object manipulation, functional hand skills, and responses to tactile information. Higher values represent better performance. The interquartile range provides adequate assessment of the variability of the data. The minimum possible value is 0 and the maximum possible value is 66.

Time frame: 9 months

Population: This outcome was measured in 178 of the original 366 participants

ArmMeasureValue (MEDIAN)
Vitamin B12Fine Motor Scale, Bayley Scales of Infant Development, 3rd Edition26 units on a scale
PlaceboFine Motor Scale, Bayley Scales of Infant Development, 3rd Edition26 units on a scale
Secondary

Gross Motor Scale, Bayley Scales of Infant Development, 3rd Edition

The Gross Motor Scale is a single scale that measures movement of the limbs and torso, static positioning (e.g., sitting, standing), dynamic movement including locomotion and coordination, balance, and motor planning. Higher values represent better performance. The interquartile range provides adequate assessment of the variability of the data. The minimum possible value is 0 and the maxiumum possible value is 72.

Time frame: 9 months

Population: This outcome was measured in 178 of the 366 enrolled participants

ArmMeasureValue (MEDIAN)
Vitamin B12Gross Motor Scale, Bayley Scales of Infant Development, 3rd Edition36 units on a scale
PlaceboGross Motor Scale, Bayley Scales of Infant Development, 3rd Edition34 units on a scale
Secondary

Kaufman's Assessment Battery for Children (KABC)

This test is used for assessing child intelligence

Time frame: 60-72 months

Secondary

Parental Version of Strengths and Difficulties Questionnaire (SDQ)

Administered at 78 months to assess childhood behavioral problems. The SDQ has 25 items and generates 5 scales: emotional problem, conduct problem, hyperactivity/inattention, peer relationship problems and pro-social behavior.

Time frame: 78 months

Secondary

Receptive Language Scale, Bayley Scales of Infant Development, 3rd Edition

The Receptive Language Scale is a single scale that measures the ability of the child to recognize sounds and understand spoken words and directions. Higher values represent better performance. The interquartile range provides adequate assessment of the variability of the data. The minimum possible score is 0 and the maximum possible score is 49.

Time frame: 9 months

Population: This outcome was measured among 178 of the 366 enrolled participants.

ArmMeasureValue (MEDIAN)
Vitamin B12Receptive Language Scale, Bayley Scales of Infant Development, 3rd Edition11 units on a scale
PlaceboReceptive Language Scale, Bayley Scales of Infant Development, 3rd Edition11 units on a scale
Secondary

The Brief P Test

The Brief P test is a measure of infant executive function based on parental rating. It will be administered at 66 months postpartum.

Time frame: 66 months postpartum

Secondary

The Wechsler Preschool and Primary Scale of Intelligence (WPPSI)

WPPSI is an intelligence test designed for children ages 2 years 6 months to 7 years 7 months. It is a paper-pencil test that will be administered during the 78 month follow up to assess child's intellectual functioning.

Time frame: 78 months

Secondary

Vineland Social Maturity Scale (VSMS)

This scale has 8 main domains which include, Self Help General, Self Help Dressing, Self Direction, Occupation, Communication, Locomotion and Socialization. It is possible to calculate Social age and Social quotient from VSMS which will provide a good idea about the social maturity of the infant. VSMS will be used in conjunction with KABC at age 60-72 months of age.

Time frame: 60-72 months

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026